Treatment of multiple sclerosis patients after 24 Natalizumab doses: a prospective observational study: the TY-STOP

Authors: Clerico, M; Schiavetti, I; De Mercanti, S; Piazza, F; Gned, D; Brescia Morra, V; Lanzillo, R; Ghezzi, A; Bianchi, A; Salemi, G; Realmuto, S; Sola, P; Vitetta, F; Cavalla, P; Superti, G; Ferraro, D; Paolicelli, D; Trojano, M; Sormani, MP; Durelli, L
Publication year: 2014
Type: Proceedings
OA Link: http://hdl.handle.net/10447/99502